Insights

Why lane risk assessment is the cleanest first use case for AI in pharma

Lane risk assessment has lived inside a single annual qualification exercise for too long. The economics of revisiting that decision continuously have changed.

From visibility to control: Lessons from the front line of pharma supply chain resilience

On demand

In a webinar hosted 6 May, Gisli Herjolfsson, CEO of Controlant, and Ruud van der Geer, Director Global Delivery Strategy at MSD, discussed what it takes to build a supply chain that doesn't just survive disruption, but responds to it in real time. This article captures the key themes from that discussion, and shares the recording below.

From dashboards to dialogue: why AI is replacing the supply chain control tower

For years, the answer to better cold chain management was ‘more dashboards.’ That era is ending, and what replaces it will look very different.

Controlant: Powering the AI workforce in pharmaceutical supply chains

Artificial intelligence in pharmaceutical supply chains is only as effective as the data it relies on. For AI to deliver real value, it must be grounded in accurate, contextual, and validated operational information. Controlant’s platform is designed with this principle at its core.

From reactive to predictive: how real-time visibility is cutting risk in the life sciences cold chain

Cold Chain Insights Podcast episode featuring Adalheidur (Ada) Pálmadóttir, VP Business Development at Controlant.

SpotSee and Controlant announce strategic collaboration to expand shipment visibility and last-mile proof for life sciences

SpotSee and Controlant today announced a strategic collaboration designed to help life sciences organizations expand shipment visibility, strengthen proof of condition and scale monitoring programs more efficiently across temperature-sensitive supply chains.